Elyse Dorsey > Kirkland & Ellis LLP > Washington DC, United States > Lawyer Profile
Kirkland & Ellis LLP Offices
1301 Pennsylvania Avenue, N.W.
Washington, D.C., 20004
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Elyse Dorsey
Position
Elyse Dorsey is a partner in the Washington, D.C., office of Kirkland & Ellis LLP. Elyse’s practice encompasses a wide array of antitrust and competition matters across the globe. She is uniquely situated to advise clients in domestic and international competition matters, given her combination of government and private practice experience.
Elyse has a focus in cutting edge competition issues, as well as privacy, data security, and consumer protection matters. She has represented clients across levels of government, from state agencies to the U.S. Supreme Court. Prior to joining Kirkland, Elyse served as Counsel to the Assistant Attorney General at the U.S. Department of Justice’s Antitrust Division. Her work at the Antitrust Division covered a spectrum of legal and policy matters, including IP and technology issues, the Division’s appellate and amicus brief programs, and its international and competition policy efforts. Elyse joined the Division from the U.S. Federal Trade Commission, where she served as Attorney Advisor to Commissioner Noah Joshua Phillips. While at the Commission, she advised on key cases, matters, and policies affecting industries across the economy–from digital and tech to pharmaceuticals and hospitals and more.
Elyse is a recognized thought leader in the antitrust and competition communities. She has been a frequent nominee and recipient of antitrust writing awards for her scholarship in this space. She has also served as an adjunct professor at George Mason University’s Scalia Law School for several years, helping to launch their Antitrust LL.M. program; and she previously served as a visiting scholar at the University of Virginia.
Lawyer Rankings
United States > Antitrust > Cartel
Kirkland & Ellis LLP has an active cartel practice that frequently sees the team representing clients from a broad range of industries on the full range of cartel issues, with price-fixing, monopolization, generic drugs, and proteins being key areas of expertise. The team is experienced in both government cartel investigations and related litigation, both in the US and abroad. James Mutchnik, Daniel Laytin, and Christa Cottrell are key members of the firm’s antitrust cartel practice. Mutchnik, an experienced litigator based in Chicago, represents corporate and individual clients in antitrust defense matters before federal and state courts and investigative agencies. Laytin and Cottrell, also in Chicago, specialize in civil and criminal cartel litigation and in complex commercial litigation, respectively. The firm’s significant governmental agency experience, exemplified by former Antitrust Division Head of Media, Entertainment and Communications Scott Scheele, was further expanded in 2022, when Elyse Dorsey, former Counsel to the Assistant Attorney General of the Antitrust Division, and Molly Kelley, also formerly at the DOJ, joined the firm. Scheele and Dorsey are based in Washington DC, while Kelley is in Chicago.
United States > Antitrust > Civil litigation/class actions: defense
Kirkland & Ellis LLP regularly defends pharmaceutical companies in antitrust and competition disputes involving a full spectrum of antitrust claims including pay-for-delay actions, pricing disputes, monopolization, and intellectual property. The team has experience in government-initiated investigations and private antitrust matters against the DOJ, the FTC, state attorney generals, competitors as well as purchaser and consumer classes. Chicago-based Daniel Laytin handles commercial, antitrust and class action litigation with recent matters raising questions of wage fixing and monopolization. Also situated in Chicago, James Mutchnik focuses on disputes surrounding domestic and international cartels and price discrimination claims while Christa Cottrell is involved in complex commercial litigation involving large companies including Blue Cross Blue Shield Association and AbbVie. Olivia Adendorff in Washington DC and Dallas is well-versed in complex commercial class actions. The firm has expanded the team with several hires from the DOJ including Scott Scheele and Elyse Dorsey in Washington DC and Molly Kelley in the firm’s Chicago office. Katherine Rocco departed from the firm in April 2022 and Sean Royall left in February 2022.
Lawyer Rankings
Top Tier Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: high-yield debt offerings
- International Trade > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Intellectual property > Copyright
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Intellectual property > Patents: litigation (full coverage)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- M&A/corporate and commercial > Shareholder activism
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
Firm Rankings
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Energy > Energy regulation: electric power
- Environment > Environment: litigation
- Media, technology and telecoms > Media and entertainment: litigation
- Antitrust > Merger control
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate investment trusts (REITs)
- Government > State attorneys general
- Finance > Structured finance: securitization
- Tax > US taxes: contentious
- Dispute resolution > E-discovery
- Dispute resolution > Financial services litigation
- Insurance > Insurance: non-contentious
- Energy > Renewable/alternative power
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Energy > Energy regulation: oil and gas
- Dispute resolution > Leading trial lawyers
- Healthcare > Life sciences
- Media, technology and telecoms > Media and entertainment: transactional
- Real estate > Construction (including construction litigation)
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Investment fund formation and management > Mutual/registered/exchange-traded funds